Pharmacist & Pharmacy Educational Information
Staying current is crucial to success in the pharmacy industry. From new drugs, to recalls, to regulations, the pharmacy industry landscape is always changing. This page will help you stay up to date with current events so check back regularly to ensure that you never miss a beat.
This page will contain updated recent and breaking news. We will also include links to articles and additional coverage of important industry news allowing you to use this page for updates or in-depth research into current pharmacy happenings. However you use it, the industry news you find here will be accurate and up to date so that you can stay informed.
Monthly Educational Newsletter / Alerts
Keep up to date on the latest regulations, developments, and industry information with this monthly electronic newsletter.
|
posted August 13, 2010
|
posted June 14, 2010
|
|
Quarterly Newsletter / Alerts
Stay on top of the latest regulations, developments, and information affecting the pharmacy industry with this quarterly electronic newsletter.
|
ISSUE DATE
|
DESCRIPTION
|
LINK TO ISSUE
|
| Summer 2010 | Topics: Quality Assurance Programs, Drug Updates and HIPAA HITECH Act | |
| Spring 2010 | Topics: Healthcare Reform, Drug Updates and Surety Bonds | |
| Winter 2010 | Topics: Drug Updates, Prescription Origin Code and Fraud, Waste & Abuse | |
| Fall 2009 | Topics: DME Accreditation Deadline and Drug Updates |
Articles
DME Accreditation: Five Things a Pharmacist Must Know | Chris Renz, PRS Pharmacy Services - Mar. 8, 2010
Time's Up! As of January 1, 2010, suppliers of durable medical equipment (DME) to Medicare patients must be accredited. Ever since the Medicare Modernization Act of 2003 first raised the specter of a DME accreditation requirement for Medicare suppliers, pharmacists and pharmacy industry associations have been fighting for an exemption. And, while pharmacists were calling their members of Congress, many were not working through the accreditation process. They gambled that Pharmacy would eventually win an exemption from DME accreditation. But, as of March 1, 2010, they have not. READ MORE...
A shortage of commercially available Tamiflu® (oseltamivir phosphate) oral suspension is contributing to dosing errors in healthcare facilities. On October 15, 2009, the Institute for Safe Medication Practices (ISMP) alerted healthcare professionals about a risk of overdoses and underdoses related to the concentration of pharmacy-compounded Tamiflu being dispensed in response to shortages of the manufacturer’s oral suspension.1 As of October 20, 2009, two reports have been submitted to the Pennsylvania Patient Safety Authority describing dosing errors related to the concentration of Tamiflu available from inpatient pharmacies. READ MORE...
